Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies

Hyperhomocysteinemia is recognized as a risk factor for several diseases, including cardiovascular and neurological conditions. Homocysteine (HCys) is a key metabolite involved in the biosynthesis and metabolism of methionine (Met), which plays a pivotal role in the physiological cell's life cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinelli, Caterina, Di Pino, Antonella, Ficulle, Elena, Marcelli, Serena, Feligioni, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491750/
https://www.ncbi.nlm.nih.gov/pubmed/31069230
http://dx.doi.org/10.3389/fnut.2019.00049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491750/
https://www.ncbi.nlm.nih.gov/pubmed/31069230
http://dx.doi.org/10.3389/fnut.2019.00049

Ejemplares similares